Home
Business
Corporate Finance
Asset Management
Wealth Management
Global Markets
Structured Finance
Research
Daily Note
Market Strategy
Macroeconomics
Securities Analysis
Customer Trading
Stock Trading
Futures Trading
Options Trading
Company News
About CMBI
Company Profile
Join Us
Contact Us
English
Simplified Chinese
Traditional Chinese
English
Home
>
Research
>
Securities Analysis
【公司研究】巨子生物 (2367 HK) - 线上2024年线上增速靓丽,上调业绩指引
Click to read the report